Mark Hazeltine
Equibles does not estimate personal net worth.
Get an email with a short summary when Exagen Inc. publishes a filing, an earnings call transcript or a press release.
Get XGN alertsAbout Mark Hazeltine
Mark Hazeltine is recorded as COO at Exagen Inc. (XGN). The newest filing on record that lists Mark Hazeltine as COO at Exagen Inc. (XGN) is dated April 28, 2022. Exagen Inc. reported in an 8-K filed December 11, 2023 that Mark Hazeltine resigned as Chief Business Officer, effective December 6, 2023. Exagen Inc. reported in an 8-K filed December 5, 2022 that Mark Hazeltine was appointed Chief Business Officer, effective December 5, 2022. The proxy statement of Exagen Inc. reports total compensation of $1,053,994 for Mark Hazeltine in fiscal 2023, including a base salary of $378,416. Disclosed compensation is on record for 3 fiscal years. Exagen Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Exagen Inc. includes John Aballi (CEO, CFO and Board Member), Tina S. Nova (Chairman), Jeffrey Black (CFO) and 6 others.
“On December 6, 2023, Mark Hazeltine resigned from his position as the Company’s Chief Business Officer.”
“On December 5, 2022, Mark Hazeltine, the Company's current Chief Operating Officer was appointed to serve as the Company's Chief Business Officer.”
Affiliation history
-
Exagen Inc. (XGN)
SEC 8-K
Current2022-12-05–present
-
Current
Start not stated–present
Last confirmed April 28, 2022
-
Exagen Inc. (XGN)
Proxy statement
Start not stated–2023-12-06
Company network
Leadership on record at Exagen Inc.
- John Aballi CEO, CFO, Board Member
- Tina S. Nova Chairman
- Jeffrey Black CFO
- Bruce C. Robertson Board Member
- Charles S. McKhann Board Member
- Frank Stokes Board Member
- Paul Kim Board Member
- Scott D. Kahn Board Member
- Scott D. Kahn, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Exagen Inc. (XGN) | former Chief Business Officer Amounts represent the aggregate grant date fair value of restricted stock unit awards granted to the named executive officer in the applicable year, as computed in accordance with ASC Topic 718, Compensation-Stock Compensation, rather than the amounts paid to or realized by the named executive officer. For a discussion of valuation assumptions used in the calculations, see Note 2 and Note 9 to our audited financial statements in our 2023 Annual Report. Amounts for 2023 represent the non-discretionary portion of cash bonuses paid in March 2024 with respect to 2023 corporate performance under the bonus plan. For additional information, see "Cash Bonuses" below. Amounts for 2023 represent employer matching contributions under our 401(k) plan on behalf of each named executive officer, and severance payments, paid time off payouts and Consolidated Omnibus Budget Reconciliation Act (COBRA) payments to Mr. Hazeltine in the amounts of $421,438, $23,599 and $15,140, respectively. | $378,416 | $1,053,994 |
| 2022 | Exagen Inc. (XGN) | former Chief Business Officer Amounts represent the aggregate grant date fair value of restricted stock unit awards granted to the named executive officer in the applicable year, as computed in accordance with ASC Topic 718, Compensation-Stock Compensation, rather than the amounts paid to or realized by the named executive officer. For a discussion of valuation assumptions used in the calculations, see Note 2 and Note 9 to our audited financial statements in our 2023 Annual Report. Amounts for 2023 represent the non-discretionary portion of cash bonuses paid in March 2024 with respect to 2023 corporate performance under the bonus plan. For additional information, see "Cash Bonuses" below. Amounts for 2023 represent employer matching contributions under our 401(k) plan on behalf of each named executive officer, and severance payments, paid time off payouts and Consolidated Omnibus Budget Reconciliation Act (COBRA) payments to Mr. Hazeltine in the amounts of $421,438, $23,599 and $15,140, respectively. | $398,507 | $1,040,175 |
| 2021 | Exagen Inc. (XGN) | Chief Business Officer | $390,563 | $1,397,753 |